Panadol

Sensodyne-Maker Haleon Posts Unexpected Drop In Revenue On Weak Demand For Its Painkiller

Haleon posted an unexpected drop in third-quarter revenue, hurt by a weak demand for its painkiller in Australia and the Middle East.

ESM’s Retail Recap: Colruyt Group, Haleon, Albert Heijn

Colruyt Group to acquire meal solutions provider Delitraiteur, Haleon develops an AI-powered tool for improved inclusivity, and Albert Heijn to switch to c...

Haleon Forecasts High Single-Digit Growth For Annual Organic Operating Profit

Haleon has forecast high single-digit growth in organic operating profit in 2024, after reporting a 4% rise in half-year pre-tax earnings amid strong deman...

Haleon Posts Tepid Q1 Sales As Demand For Some Products Cool Off

Consumer healthcare company Haleon reported first-quarter revenue slightly below market estimates as volumes declined.

Haleon Forecasting 4% To 6% Revenue Growth this Year

Haleon, the world's biggest standalone consumer health business, has forecast 4% to 6% organic revenue growth in 2023.

Consumer Health Firm Haleon Posts 16.1% Jump In Quarterly Sales

Haleon, the former consumer health arm of GSK, has reported a 16.1% increase in third-quarter reported revenue as it raised prices, and lifted its sales ou...

Haleon Sees Revenue Up 13.4% In First Half

British consumer healthcare company Haleon, which GSK recently officially spun off, has reported revenue growth of 13.4% (up 11.6% in t), to £5.2 bil...

GSK, Pfizer, To Create Consumer Health-Care Giant

GlaxoSmithKline (GSK) plans to split into two businesses – one for prescription drugs and vaccines, the other for over-the-counter products &nda...

Subscribe Today

Get the app today!